Montalban X, et al. Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients With Primary Progressive Multiple Sclerosis in the ORATORIO Trial. PR2086. EAN 2017.
Casus: Patiënt met diabetische voet
feb 2015 | Diabetes
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen